KY
Kyverna Therapeutics, Inc.
KYTX · NASDAQ
$6.90 -1.71% (-$0.12)
1M -18.82%
Market Cap $419.5M
P/E Ratio -
Div. Yield -
ROE 81.91%
Piotroski F-Score Weak
1/9Valuation
74 /100
Cheap P/B 2.53x
PEG N/A
P/S N/A
Growth
100 /100
Growing Book val. growth 70.73%
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROE 81.91%
ROA 69.44%
Asset turnover 0.00x
Debt
69 /100
Low Current ratio 9.06x
Int. coverage -85.23x
Debt/Equity 0.20x
Stability
1 /100
Unstable EPS volatility 1,922,544.84%
Profitable years 0
Beta 1.99x
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na KYTX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Warner Biddle
Employees
149
Headquarters
Emeryville
Nadcházející události
11 LIS
Earnings
Upcoming earnings report